Aion Therapeutic Stock Buy Hold or Sell Recommendation
| ANTCF Stock | USD 0.03 0.02 185.71% |
Assuming the 90 days horizon and your complete indifference towards market risk, our recommendation regarding Aion Therapeutic is 'Cautious Hold'. Macroaxis provides Aion Therapeutic buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ANTCF positions.
Check out Aion Therapeutic Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Aion and provide practical buy, sell, or hold advice based on investors' constraints. Aion Therapeutic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Aion |
Execute Aion Therapeutic Buy or Sell Advice
The Aion recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aion Therapeutic. Macroaxis does not own or have any residual interests in Aion Therapeutic or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aion Therapeutic's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Aion Therapeutic Trading Alerts and Improvement Suggestions
| Aion Therapeutic is way too risky over 90 days horizon | |
| Aion Therapeutic has some characteristics of a very speculative penny stock | |
| Aion Therapeutic appears to be risky and price may revert if volatility continues | |
| Aion Therapeutic has high likelihood to experience some financial distress in the next 2 years | |
| Aion Therapeutic has accumulated 643.8 K in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Aion Therapeutic has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Aion Therapeutic until it has trouble settling it off, either with new capital or with free cash flow. So, Aion Therapeutic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aion Therapeutic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aion to invest in growth at high rates of return. When we think about Aion Therapeutic's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.82 M) with loss before overhead, payroll, taxes, and interest of (1.5 K). | |
| Aion Therapeutic has accumulated about 1.85 K in cash with (1.35 M) of positive cash flow from operations. | |
| Roughly 18.0% of Aion Therapeutic shares are held by company insiders |
Aion Therapeutic Returns Distribution Density
The distribution of Aion Therapeutic's historical returns is an attempt to chart the uncertainty of Aion Therapeutic's future price movements. The chart of the probability distribution of Aion Therapeutic daily returns describes the distribution of returns around its average expected value. We use Aion Therapeutic price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aion Therapeutic returns is essential to provide solid investment advice for Aion Therapeutic.
| Mean Return | 11.92 | Value At Risk | -48.53 | Potential Upside | 84.21 | Standard Deviation | 51.50 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aion Therapeutic historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aion Therapeutic Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aion Therapeutic or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aion Therapeutic's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aion pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 14.15 | |
β | Beta against Dow Jones | -17.56 | |
σ | Overall volatility | 62.49 | |
Ir | Information ratio | 0.19 |
Aion Therapeutic Volatility Alert
Aion Therapeutic is displaying above-average volatility over the selected time horizon. Aion Therapeutic is a penny stock. Although Aion Therapeutic may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Aion Therapeutic. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Aion instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Aion Therapeutic Fundamentals Vs Peers
Comparing Aion Therapeutic's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aion Therapeutic's direct or indirect competition across all of the common fundamentals between Aion Therapeutic and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aion Therapeutic or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Aion Therapeutic's fundamental indicators could also be used in its relative valuation, which is a method of valuing Aion Therapeutic by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aion Therapeutic to competition |
| Fundamentals | Aion Therapeutic | Peer Average |
| Return On Equity | -4.17 | -0.31 |
| Return On Asset | -0.96 | -0.14 |
| Current Valuation | 1.22 M | 16.62 B |
| Shares Outstanding | 147.3 M | 571.82 M |
| Shares Owned By Insiders | 17.68 % | 10.09 % |
| Price To Book | 5.77 X | 9.51 X |
| Gross Profit | (1.5 K) | 27.38 B |
| EBITDA | (3.68 M) | 3.9 B |
| Net Income | (3.82 M) | 570.98 M |
| Cash And Equivalents | 1.85 K | 2.7 B |
| Total Debt | 643.8 K | 5.32 B |
| Debt To Equity | 0.14 % | 48.70 % |
| Current Ratio | 0.15 X | 2.16 X |
| Book Value Per Share | (0.01) X | 1.93 K |
| Cash Flow From Operations | (1.35 M) | 971.22 M |
| Earnings Per Share | (0.04) X | 3.12 X |
| Number Of Employees | 4 | 18.84 K |
| Beta | 0.29 | -0.15 |
| Market Capitalization | 1.47 M | 19.03 B |
| Total Asset | 150.14 K | 29.47 B |
| Z Score | -78.0 | 8.72 |
| Net Asset | 150.14 K |
Aion Therapeutic Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aion . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 2.86 | |||
| Day Median Price | 0.03 | |||
| Day Typical Price | 0.03 | |||
| Price Action Indicator | 0.0098 | |||
| Period Momentum Indicator | 0.0195 | |||
| Relative Strength Index | 61.81 |
About Aion Therapeutic Buy or Sell Advice
When is the right time to buy or sell Aion Therapeutic? Buying financial instruments such as Aion Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aion Therapeutic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Books Thematic Idea Now
Books
Companies involved in publishing of books, newspapers, periodicals and other mass publications. The Books theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Books Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Aion Pink Sheet
Aion Therapeutic financial ratios help investors to determine whether Aion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aion with respect to the benefits of owning Aion Therapeutic security.